India Global Business Staff2020-12-08T10:38:50+00:00December 8th, 2020|In Focus: Covid-19 impact, India Inc Views - India Global Business|
As the vision of the Covid-19 vaccine is set to become a reality the government will not abandon its commitment to provide vaccines for the low and medium income countries following the roll out at home.
India Global Business Staff2020-12-07T15:03:06+00:00December 7th, 2020|India Inc Views - India Global Business, News in Brief|
Serum Institute of India, the world's largest vaccine producer by volume, has sought approval for emergency use of AstraZeneca Plc's COVID-19 vaccine in the country.
India Global Business Staff2020-12-07T15:17:06+00:00December 7th, 2020|Editorials - India Global Business|
The Serum Institute of India and Pfizer Inc have sought emergency use authorisation, pending approval by the government authorities.
India Global Business Staff2021-01-25T14:16:11+00:00December 1st, 2020|The Big Story - India Global Business|
An increasingly strategic global responsibility has emerged in which the Modi government could be seen as a critical pillar in the fight against the pandemic.
India Global Business Staff2020-12-01T04:46:46+00:00November 30th, 2020|India Inc Views - India Global Business, News in Brief|
The Indian Council of Medical Research (ICMR) is assisting an inquiry into an alleged adverse reaction during AstraZeneca's COVID-19 vaccine trial, but has found no reason to recommend halting it, a senior official at the regulator said on Sunday.
India Global Business Staff2020-11-30T06:23:00+00:00November 27th, 2020|India Inc Views - India Global Business, News in Brief|
Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year under the terms of a deal unveiled on Friday between it and Russia's RDIF sovereign wealth fund.
India Global Business Staff2020-11-27T09:09:55+00:00November 26th, 2020|Analysis - India Global Business, India Inc Views - India Global Business|
Driven by rising adoption of emerging technologies like Big Data, IoT and AI across e-governance platforms, sector's revenue to exceed $16 billion by 2024.
India Global Business Staff2020-11-20T06:14:05+00:00November 19th, 2020|India Inc Views - India Global Business, News in Brief|
Businesses today are leading through uncertainty and addressing concerns with optimism to return to normalcy in 12-18 months time frame according to the survey released by American Express India.
Arnab Mitra2020-11-18T14:50:58+00:00November 18th, 2020|India Inc Views - India Global Business|
Barring the emergence of a second wave, India seems to have the Covid situation largely under control. This is giving the government more headroom to focus on reviving the pandemic-hit economy and putting it back on a high growth trajectory.
India Global Business Staff2020-11-10T03:36:41+00:00November 9th, 2020|India Inc Views - India Global Business, News in Brief|
India has handled the COVID-19 pandemic much better with the estimated confirmed cases, a research report by State Bank of India (SBI).
